AUSTIN, TEXAS, SEPTEMBER 7th, 2023 - Fagron Sterile Services US (FSS), a prominent 503B Outsourcing Facility, is proud to announce their selection as a recipient of a 2023 Project PROTECT grant awarded by Angels for Change. This accolade recognizes FSS as a dedicated Protector of Dextrose and certifies FSS’s commitment to safeguarding patient and prescriber access to this essential medication and alleviating drug shortages currently plaguing the United States.
“FSS remains committed to innovation, quality, and safety within pharmaceutical compounding. By partnering with Angels for Change, which is at the forefront of addressing the critical issue of drug shortages, we are contributing to the overall well-being of communities across the United States, in a meaningful way,” said Ray Dixon, SVP, Commercial, FSS. Read more >
Fagron North America is a group of innovative, pharmaceutical facilities that focus on optimizing and innovating pharmaceutical compounding. Fagron North America is fully integrated with facilities specializing in 503A Compounding, 503B Human Drug Outsourcing, and providing pharmacists with raw ingredients, supplies, education, and technical support.
